home > events calendar > more about event

14th World Advanced Therapies & Regenerative Medicine Congress 2018


16-18 May 2018
Business Design Centre, London, United Kingdom

In May 2018 the World Advanced Therapies & Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs (Advanced Therapy Medicinal Products). From clinical translation to commercialisation this congress will bring you the most exciting case studies and new data for stem cells, gene therapy, TCRs and gene editing. Experts in every area will help you tackle the process and regulatory hurdles of developing all new therapeutic formats all the way through manufacture and into the clinic.

The event will take place alongside the co-located World Precision Medicine Congress, hosting300+ speakers, 10 tracks of content across the 3 days, enabling networking opportunities with 800+ leading industry professionals.

For a 15% discount on your conference ticket, quote code ‘HMFQ’ at the online checkout

Confirmed speakers include:

                   Susan Solomon, CEO and Co-Founder, New York Stem Cell Foundation

                   Sven Kili, Vice President & Head, Gene Therapy Development, GSK

                   Eric Soller, Vice President of Corporate Development & Strategy, BlueRock Therapeutics

                   Margo Roberts, CSO, Kite Pharma

                   Sue Hill, Chief Scientific Officer, NHS

                   Brad Perkins, Chief Medical Officer, Human Longevity

                   Julia Wilson, Associate Director, Wellcome Trust Sanger Institute

                   Paul P. Tak, Academic Medical Centre, University of Amsterdam;  Senior Vice President of Research & Development Pipeline, Chief Immunology Officer, GSK

                   Elizabeth Shpall, Director, MD Anderson Cancer Center

                   Joanne Kurtzberg, Director, Carolinas Cord Blood Bank, Duke University

                   Todd McAllister, Executive Director, Amnion Foundation

                   Colleen Delaney, Founder and Chief Medical Officer, Nohla Therapeutics

                   Ajan Reginald, Chief Executive Officer, Celixir

                   Alain Vertès, Managing Director, NxR Biotechnologies

                   André Choulika, Chairman & Chief Executive Officer, Cellectis

                   Benjamin Shepherd, Director, Therapeutics, Organovo

                   Eduardo Bravo, Managing Director and CEO, TiGenix

                   Giuseppe Mazza, Chief Executive & Scientific Officer, Engitix

                   James Miskin, Chief Technical Officer, Oxford BioMedica

                   Jane Lebkowski, ‎President of R&D, Asterias Biotherapeutics

                   Jeff Abbey, CEO, Argos Therapeutics

                   John Tchelingerian, CEO, Promethera, Biosciences

                   Katy Spink, Chief Operating Officer, Asterias Biotherapeutics

                   Kristin Comella, Chief Science Officer, US Stem Cell Inc

                   Michael Stein, Chairman & CEO, Oxstem

                   Michael West, CEO, BioTime; CEO , AgeX Therapeutics

                   Nick Crabb, Programme Director – Scientific Affairs, NICE

                   Todd McAllister, Executive Director, Amnion Foundation

                   Yen Choo, CEO, Progenitor Therapeutics

                   Zami Aberman, Chairman & CEO, Pluristem Therapeutics

Key topics include:

                   The next generation of ATMPs

                   Regulation, reimbursement & commercialisation for advanced therapies around the globe

                   CRISPR & gene editing

                   Stem cells as a tool for drug discovery

                   What’s next for cell and gene therapy, new era of regenerative medicine?

                   New paradigms in manufacture: gene therapy & viral vectors

                   Clinical development of immunotherapy & cell therapy

                   New frontiers in repair and replacement of diseased tissues & organs

                   Product, process & manufacturing development of ATMPS

For a 15% discount on your conference ticket, quote code ‘HMFQ’ at the online checkout

phone +44 (0)20 7092 1000
email Business Design Centre, London
Print this page
Send to a friend
Industry Events

SMi’s 9th Annual Biosimilars & Biobetters Conference

25-27 September 2018, Copthorne Tara Hotel, London, UK

Following the success of our previous events in both London and the US, Biosimilars and Biobetters UK 2018, SMi deliver a stellar speaker line-up and bring together a global audience of biosimilar experts to discuss the latest developments and future of the rapidly evolving and expanding biosimilars market.
More info >>

White Papers

Transforming Temperature Data Management Practices to Reduce Labor Costs and Improve Visibility and Control

Berlinger & Co AG

There are a number of temperature monitoring database options available to the biopharma supply chain professional and choosing the right one can significantly improve workflow which will reduce administrative time. This article will provide insight into practices for improving common processes through enhanced database functionality in the areas of managing data loggers by expiry date, storing and retrieving calibration certificates and acknowledging/documenting common temperature excursion events. Additionally, it describes the unique features and benefits of the Berlinger Smartview® data management system. Smartview® is a “Software as a Service” (SaaS) platform designed to efficiently and accurately manage both workflow and data in a regulatory compliant manner (21 CRF Part 11 & Annex 11). This comprehensive temperature data management system ensures reliability, accuracy, security, accessibility, and visibility to supply chain professionals, enhancing Good Distribution Practices (GDP) of temperature sensitive shipments.
More info >>

News and Press Releases

Biologics Day

On 20. July 2018, Phenomenex and SCIEX will co-host a full day of seminars, providing solutions for Biologics. The series of mini-seminars presented by technical experts from both companies, will cover methods for characterisation and QC testing, troubleshooting and new trends in analysis for this industry.  
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement